Serial alterations and prognostic implications of myocardial perfusion and fatty acid metabolism in patients with acute myocardial infarction

Circulation Journal

Volumn 70, Issue 11, 2006, Pages 1466-1474

  Hashimoto, Akiyoshi ^a   Nakata, Tomoaki ^a   Tamaki, Nagara ^b   Kobayashi, Takeshi ^c   Matsuki, Takayuki ^c   Shogase, Takashi ^c   Furudate, Masayori ^c  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Hokkaido Cardiac Metabolism Imaging Study Group   (Japan)

Author keywords

Metabolism; Myocardial infarction; Myocardial perfusion imaging; Outcome research

Indexed keywords

15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; CALCIUM CHANNEL BLOCKING AGENT; NITRATE;

ACUTE HEART INFARCTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; FATTY ACID METABOLISM; FEMALE; HEART FAILURE; HEART MUSCLE PERFUSION; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PROGNOSIS;

ACUTE DISEASE; AGED; CORONARY CIRCULATION; FATTY ACIDS; FEMALE; HUMANS; IODOBENZENES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIUM; PROGNOSIS; RADIONUCLIDE IMAGING; RISK FACTORS;

EID: 33750565585     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1466     Document Type: Article

References (28)

1. Nakata T, Hashimoto A, Eguchi M. Cardiac BMIPP imaging in acute myocardial infarction. Int J Card Imaging 1999; 14: 21-26.
2. Hashimoto A, Nakata T, Tsuchihashi K, Shigemichi T, Kenji F, Osamu I. Post-ischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 1996; 77: 25-30.
3. Kobayashi H, Kusakabe K, Momose M, Okawa T, Inoue S, Iguchi N, et al. Evaluation of myocardial perfusion and fatty acid uptake using a single injection of iodine-123-BMIPP in patients with acute coronary syndromes. J Nucl Med 1998; 39: 1117-1122.
4. Yamagishi H, Akioka K, Takagi M, Tanaka A, Takeuchi K, Yoshikawa I, et al. Relation between the kinetics of thallium-201 in myocardial scintigraphy and myocardial metabolism in patients with acute myocardial infarction. Heart 1998; 80: 28-34.
5. Kawai Y, Tsukamoto E, Nozaki Y, Morita K, Sakurai M, Tamaki N, et al. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardial 2001; 38: 1888-1894.
6. Takeishi Y, Fujiwara S, Atsumi H, Takahashi K, Sukekawa H, Tomoike H, et al. Iodine-123-BMIPP imaging in unstable angina: A guide for interventional strategy. J Nucl Med 1997; 38: 1407-1411.
7. Morimoto K, Tomoda H, Yoshitake M, Aoki N, Handa S, Suzuki Y, et al. Prediction of coronary artery lesions in unstable angina by iodine 123 beta-methyl iodophenyl pentadecanoic acid (BMIPP), a fatty acid analogue, single photon emission computed tomography at rest. Angiology 1999; 50: 639-648.
8. Nakata T, Hashimoto A, Kobayashi H, Miyamoto K, Tsuchihashi K, Miura T, et al. Outcome significance of thallium and iodine-123-BMIPP perfusion-metabolism mismatch in pre infarction angina. J Nucl Med 1998; 39: 1492-1499.
9. Franken PR, De Geeter F, Dendale P, Demoor D, Block P, Bossuyt A. Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: Correlation with wall motion and inotropic reserve. J Nucl Med 1994; 35: 1758-1765.
10. Franken PR, Dendale P, De Geeter F, Demoor D, Bossuyt A, Block P. Prediction of functional outcome after myocardial infarction using BMIPP and sestamibi scintigraphy. J Nucl Med 1996; 37: 718-722.
11. Fujino T, Ishii Y, Takeuchi T, Hirasawa K, Tateda K, Kikuchi K, et al. Recovery of BMIPP uptake and regional wall motion in insulin resistant patients following angioplasty for acute myocardial infarction. Circ J 2003; 67: 757-762.
12. 201Tl single photon emission computed tomography: A multicenter trial. Ann Nucl Med 1998; 12: 237-248.
13. Nakata T, Kobayashi T, Tamaki N, Kobayashi H, Wakabayashi T, Shimoshige S, et al. Prognostic value of impaired myocardial fatty acid uptake in patients with acute myocardial infarction. Nucl Med Commun 2000; 21: 897-906.
14. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methyl-branched fatty acid analogue, iodine-125-15-(-p-iodophenyl)-3-(R,S) methylpentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990; 31: 1818-1822.
15. Schwaiger M, Schelbert H, Ellison D, Hansen H, Yeatman L, Vinten-Johansen J, et al. Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model. J Am Coll Cardiol 1985; 6: 336-346.
16. Pollock SG, Abbott RD, Boucher CA, Beller AG, Kaul S. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease: Validation of models based on these tests. Circulation 1992; 85: 237-248.
17. Taki J, Nakajima K, Matsunari I, Bunko H, Takata S, Kawasuji M, et al. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP. J Nucl Med 1997; 38: 1503-1510.
18. Kawamoto M, Tamaki N, Yonekura Y, Tadamura E, Fujibayashi Y, Magata Y, et al. Combined study with I-123 fatty acid and thallium-201 to assess ischemic myocardium: Comparison with thallium redistribution and glucose metabolism. Ann Nucl Med 1994; 8: 47-54.
19. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994; 73: 527-533.
20. Tamaki N, Kawamoto M, Takahashi N, Yonekura Y, Magata Y, Nohara R, et al. Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: Comparison with stress thallium imaging. J Am Coll Cardiol 1993; 22: 1621-1627.
21. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 1990; 66: 913-931.
22. Nienaber CA, Brunken RC, Sherman CT, Yeatman LA, Gambhir SS, Krivokapich J, et al. Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol 1991; 18: 966-978.
23. Ryan TJ, Antman EL, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: 1999 update: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (committee on management of acute myocardial infarction). Available at: http://www.acc.org/clinical/ guidelines/nov96/1999/dirindex.htm (accessed July 30, 2002).
24. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: Executive summary: Report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (ACC/AHA/ASNC committee to revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). J Am Coll Cardiol 2003; 42: 1318-1333.
25. Nakata T, Katagiri Y, Odawara Y, Eguchi M, Kuroda M, Tsuchihashi K, et al. Two- and three-dimensional assessments of myocardial perfusion and function by technetium-99m sestamibi gated single-photon emission computed tomography using a combination of count- and image-based techniques. J Nucl Cardiol 2000; 7: 623-632.
26. Matsuki T, Tamaki N, Nakata T, Doi A, Takahashi H, Iwata M, et al. Prognostic value of fatty aid imaging in patients with angina pectoris without prior myocardial infarction: Comparison with stress thallium imaging. Eur J Nucl Med Mol Imaging 2004; 31: 1585-1591.
27. Seki H, Toyama T, Higuchi K, Kasama S, Ueda T, Seki R, et al. Prediction of functional improvement of ischemic myocardium with (123I-BMIPP SPECT and 99mTc-tetrofosmin SPECT imaging: A study of patients with large acute myocardial infarction and receiving revascularization therapy. Circ J 2005; 69: 311-319.
28. Tani T, Teragaki M, Watanabe H, Muro T, Yamagishi H, Akioka K, et al. Detecting viable myocardium and predicting functional improvement: Comparisons of positron emission tomography, rest-redistribution thallium-201 single-photon emission computed tomography (SPECT), exercise thallium-201 reinjection SPECT, I-123 BMIPP SPECT and dobutamine stress echocardiography. Circ J 2004; 68: 950-957.